Trial Profile
The study of usefulness and safety of pregabalin for numbness of spinal disease
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 11 Apr 2021
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Spinal cord disorders
- Focus Therapeutic Use
- 11 Apr 2017 New trial record